Anna Ip is a Scientist at Amgen with extensive experience in analytical method development and optimization, having previously worked at SRI International from 1987 to 1992 as a Research Associate. At Amgen, Anna has applied DOE Quality by Design principles in the rapid development of HPLC analytical methods and contributed to IND sections for FDA filings. Anna holds a degree in Chemical Engineering from the University of California, Berkeley, completed in 1987, and has co-authored a chapter in ACS Books on biopharmaceutical characterization.
This person is not in the org chart
This person is not in any teams
This person is not in any offices